Summary of the recommendations on sexual dysfunctions in men.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 21040491)

Published in J Sex Med on November 01, 2010

Authors

Francesco Montorsi1, Ganesan Adaikan, Edgardo Becher, Francois Giuliano, Saad Khoury, Tom F Lue, Ira Sharlip, Stanley E Althof, Karl-Eric Andersson, Gerald Brock, Gregory Broderick, Arthur Burnett, Jacques Buvat, John Dean, Craig Donatucci, Ian Eardley, Kerstin S Fugl-Meyer, Irwin Goldstein, Geoff Hackett, Dimitris Hatzichristou, Wayne Hellstrom, Luca Incrocci, Graham Jackson, Ates Kadioglu, Laurence Levine, Ronald W Lewis, Mario Maggi, Marita McCabe, Chris G McMahon, Drogo Montague, Piero Montorsi, John Mulhall, Jim Pfaus, Hartmut Porst, David Ralph, Raymond Rosen, David Rowland, Hossein Sadeghi-Nejad, Ridwan Shabsigh, Christian Stief, Yoram Vardi, Kim Wallen, Marlene Wasserman

Author Affiliations

1: Department of Urology, San Raffaele Hospital, Milan, Italy. montorsi.francesco@hsr.it

Associated clinical trials:

Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV) (STEDOV) | NCT02450188

Articles citing this

Geometrical modified nesbit corporoplasty to correct different types of penile curvature: description of the surgical procedure based on geometrical principles and long-term results. Int J Impot Res (2016) 1.39

Management of priapism: an update for clinicians. Ther Adv Urol (2014) 0.98

Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial. EBioMedicine (2016) 0.95

Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol (2012) 0.88

Udenafil for the treatment of erectile dysfunction. Ther Clin Risk Manag (2014) 0.86

Current and emerging treatment options for Peyronie's disease. Res Rep Urol (2013) 0.86

On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial. Arab J Urol (2013) 0.85

Avanafil for treatment of erectile dysfunction: review of its potential. Vasc Health Risk Manag (2012) 0.85

Chronic Cigarette Smoking Impairs Erectile Function through Increased Oxidative Stress and Apoptosis, Decreased nNOS, Endothelial and Smooth Muscle Contents in a Rat Model. PLoS One (2015) 0.84

Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. Ther Adv Urol (2013) 0.82

Advances in the treatment of erectile dysfunction: what's new and upcoming? F1000Res (2016) 0.80

2015 CUA Practice guidelines for erectile dysfunction. Can Urol Assoc J (2015) 0.80

Is erectile dysfunction a reliable indicator of general health status in men? Arab J Urol (2013) 0.80

Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction. Exp Ther Med (2015) 0.78

Udenafil: efficacy and tolerability in the management of erectile dysfunction. Ther Adv Urol (2013) 0.77

Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature. Int Urol Nephrol (2014) 0.77

Satisfaction assessment with malleable prosthetic implant of Spectra (AMS) and Genesis (Coloplast) models. Int J Impot Res (2016) 0.76

Management of erectile dysfunction post-radical prostatectomy. Res Rep Urol (2015) 0.76

Radiotherapy for prostate cancer and sexual health. Transl Androl Urol (2015) 0.75

Implementing international sexual counselling guidelines in hospital cardiac rehabilitation: development of the CHARMS intervention using the Behaviour Change Wheel. Implement Sci (2016) 0.75

Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience. Ther Adv Urol (2016) 0.75

Association of nNOS and Rho-kinase with age-associated erectile dysfunction in Sprague-Dawley rats. Exp Ther Med (2017) 0.75

The Relationship between Neovascular Age-Related Macular Degeneration and Erectile Dysfunction. J Ophthalmol (2013) 0.75

Association of Hypertension With Erectile Function in Chronic Peripheral Arterial Insufficiency Patients. J Clin Med Res (2016) 0.75

Orgasmic Dysfunction after Radical Prostatectomy. World J Mens Health (2017) 0.75

Sexual function and male cancer. Transl Androl Urol (2013) 0.75

A critical analysis of the surgical outcomes for the treatment of Peyronie's disease. Arab J Urol (2013) 0.75

Erectile dysfunction treatment and traditional medicine-can East and West medicine coexist? Transl Androl Urol (2017) 0.75

Can lifestyle modification affect men's erectile function? Transl Androl Urol (2016) 0.75

Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction. J Sex Med (2015) 0.75

The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction. PLoS One (2016) 0.75

The Decline of Inpatient Penile Prosthesis over the 10-Year Period, 2000-2010. Sex Med (2015) 0.75

Articles by these authors

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med (2006) 5.63

The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther (2005) 5.42

The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med (2003) 5.30

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol (2006) 5.20

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 4.94

Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol (2013) 4.58

Private practice is unethical-and doctors should give it up. BMJ (2015) 3.92

American Urological Association guideline on the management of priapism. J Urol (2003) 3.77

Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55

Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol (2008) 3.50

The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol (2003) 3.31

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol (2004) 3.30

Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol (2003) 3.23

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (2006) 3.23

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol (2008) 3.21

Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol (2009) 3.18

Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol (2004) 2.91

Men and women differ in amygdala response to visual sexual stimuli. Nat Neurosci (2004) 2.89

Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 2.85

Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.81

Root zone sensors for irrigation management in intensive agriculture. Sensors (Basel) (2009) 2.79

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol (2010) 2.75

Coronary in-stent restenosis: assessment with CT coronary angiography. Radiology (2012) 2.75

Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study. Eur Urol (2008) 2.74

Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.73

Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63

Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med (2011) 2.63

Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol (2005) 2.62

Sleep loss and fatigue in residency training: a reappraisal. JAMA (2002) 2.55

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol (2002) 2.50

Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc Interv (2012) 2.47

Erectile dysfunction: management update. CMAJ (2004) 2.43

EAU guidelines on penile curvature. Eur Urol (2012) 2.40

Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunction. Eur Urol (2008) 2.38

A long-term prognostic value of coronary CT angiography in suspected coronary artery disease. JACC Cardiovasc Imaging (2012) 2.35

Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) (2004) 2.35

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 2.33

Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int (2012) 2.31

Comparison of a new length measurement technique for inflatable penile prosthesis implantation to standard techniques: outcomes and patient satisfaction. J Sex Med (2011) 2.29

Prevalence and risk factors for low sexual function in women: a study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med (2008) 2.26

BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur Urol (2005) 2.26

Single-step percutaneous nephrolithotomy (microperc): the initial clinical report. J Urol (2011) 2.25

Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med (2006) 2.23

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. J Clin Oncol (2005) 2.20

Penile constriction devices: case report, review of the literature, and recommendations for extrication. J Sex Med (2008) 2.19

Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics (2003) 2.17

Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17

Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med (2010) 2.17

Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry (2006) 2.13

The effects of sleep loss and fatigue on resident-physicians: a multi-institutional, mixed-method study. Acad Med (2004) 2.13

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol (2012) 2.11

Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol (2005) 2.11

A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol (2011) 2.11

Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause (2012) 2.09

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin (2004) 2.03

Burkitt's lymphoma. Lancet (2012) 2.02

Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol (2006) 2.01

Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99

Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med (2014) 1.99

Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96

What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int (2005) 1.95

Urinary incontinence in women: part 1 of a series of articles on incontinence. Dtsch Arztebl Int (2010) 1.95

An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med (2008) 1.95

Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93

The management of Peyronie's disease: evidence-based 2010 guidelines. J Sex Med (2010) 1.91

An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care (2011) 1.91

Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int (2008) 1.88

Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort. Diabetes Care (2009) 1.87

Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87

Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol (2012) 1.83

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83